These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 24615194)
1. Hypofractionated conformal radiotherapy in combination with chemotherapy in limited disease small cell lung cancer patients. Socha J; Guzowska A; Tyc-Szczepaniak D; Szczęsna A; Kępka L Pneumonol Alergol Pol; 2014; 82(2):105-15. PubMed ID: 24615194 [TBL] [Abstract][Full Text] [Related]
2. Accelerated hypofractionated thoracic radiotherapy in limited disease small cell lung cancer : comparison with the results of conventionally fractionated radiotherapy. Socha J; Guzowska A; Tyc-Szczepaniak D; Wierzchowski M; Sprawka A; Szczesna A; Kepka L J BUON; 2015; 20(1):146-57. PubMed ID: 25778310 [TBL] [Abstract][Full Text] [Related]
3. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer. Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy. Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924 [TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
6. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer. Sas-Korczynska B; Sokolowski A; Korzeniowski S Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy]. Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis. Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253 [TBL] [Abstract][Full Text] [Related]
9. Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma. Wong AT; Rineer J; Schwartz D; Becker D; Safdieh J; Osborn V; Schreiber D Clin Lung Cancer; 2017 Mar; 18(2):207-212. PubMed ID: 27686970 [TBL] [Abstract][Full Text] [Related]
10. Treatment modality selection and prognosis of early stage small cell lung cancer: retrospective analysis from a single cancer institute. Zhu H; Zhou Z; Xue Q; Zhang X; He J; Wang L Eur J Cancer Care (Engl); 2013 Nov; 22(6):789-96. PubMed ID: 23763282 [TBL] [Abstract][Full Text] [Related]
11. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base. Sher DJ; Koshy M; Liptay MJ; Fidler MJ Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108 [TBL] [Abstract][Full Text] [Related]
12. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer. Rojas AM; Lyn BE; Wilson EM; Williams FJ; Shah N; Dickson J; Saunders MI Cancer; 2006 Sep; 107(6):1321-30. PubMed ID: 16902985 [TBL] [Abstract][Full Text] [Related]
13. Accelerated hypofractionated radiotherapy with concomitant chemotherapy in locally advanced squamous cell carcinoma of lung: evaluation of response, survival, toxicity and quality of life from a Phase II randomized study. Roy S; Pathy S; Mohanti BK; Raina V; Jaiswal A; Kumar R; Kalaivani M Br J Radiol; 2016 Jun; 89(1062):20150966. PubMed ID: 26986459 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations. Han J; Fu C; Li B Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551 [TBL] [Abstract][Full Text] [Related]
16. Concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (Stage III) non-small-cell lung cancer: single institution experience with 600 patients. Jeremić B; Miličić B; Milisavljevic S Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1157-63. PubMed ID: 21640518 [TBL] [Abstract][Full Text] [Related]
17. Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer. Ge XH; Lin Q; Ren XC; Liu YE; Chen XJ; Wang DY; Wang YQ; Cao B; Li ZG; Liu ML Radiat Oncol; 2013 Oct; 8():238. PubMed ID: 24125485 [TBL] [Abstract][Full Text] [Related]
18. Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China. Su S; Li T; Lu B; Wang X; Li J; Chen M; Lu Y; Bai Y; Hu Y; Ouyang W; Ma Z; Li Q; Li H; Wang Y Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):769-77. PubMed ID: 26530745 [TBL] [Abstract][Full Text] [Related]
19. Radiotherapy alone vs. radiochemotherapy in patients with favorable prognosis of clinical stage IIIA non-small-cell lung cancer. Jeremić B; Miličić B; Milisavljević S Clin Lung Cancer; 2013 Mar; 14(2):172-80. PubMed ID: 23291254 [TBL] [Abstract][Full Text] [Related]
20. Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy. Stanic K; Vrankar M; But-Hadzic J Radiol Oncol; 2020 Jul; 54(3):353-363. PubMed ID: 32726294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]